Citius Pharmaceuticals (CTXR) Stock Analysis: AI Score & Alternative Data
Citius Pharmaceuticals — alt-data steady across 90 days
Is Citius Pharmaceuticals a buy right now? The alternative data says hold. This CTXR stock analysis is built on the 25+ alternative data signals AltIndex tracks on Citius Pharmaceuticals every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 47/100: a Hold. The stock trades at $0.59 with a $16M market cap.
No core signal has moved more than 5% in 90 days — steady, but without the momentum that pushes a stock into buy territory.
CTXR’s broader alt-data profile also covers headcount (19 employees, according to LinkedIn), and web traffic (5K monthly visits). Every signal links to its own page with full history, the CTXR technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on CTXR is just below.
Citius Pharmaceuticals AI Stock Analysis
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing critical care products with a focus on oncology, anti-infectives, and unique prescription products.
Analysis generated September 2, 2026.
Recent Citius Pharmaceuticals Stock Alerts
|
Citius Pharmaceuticals | August 28 Price is down by -6.2% in the last 24h. |
|
Citius Pharmaceuticals | August 27 Price is up by 6.4% in the last 24h. |
|
Citius Pharmaceuticals | August 25 Price is up by 6.2% in the last 24h. |
|
Citius Pharmaceuticals | August 20 Price is down by -8% in the last 24h. |
Citius Pharmaceuticals Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 5K | 1.8% | |
| Job Posts | 0 | 100.0% | |
| LinkedIn Employees | 19 | 0% | |
| Sentiment | 0 | 100.0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 3 | 200.0% | |
| Stocktwits Mentions | 4 | 77.8% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 21K | 0% | |
| 4chan Mentions | 0 | N/A |
About Citius Pharmaceuticals (CTXR)
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products. The company is headquartered in Cranford, New Jersey.
| Price | $0.59 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $16M |
| Year Range | $0 – $2 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Auto Parts |
Latest Citius Pharmaceuticals News
View more → |
Citius Pharmaceuticals to Participate in September 2026 Investor ConferencesSeptember 3 - PRNewswire |
 |
Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business UpdateAugust 14 - PRNewswire |
 |
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business UpdateMay 15 - PRNewswire |
 |
Citius Pharmaceuticals Q1 Earnings Report: What Investors Need to KnowFebruary 12 - Benzinga |
Citius Pharmaceuticals' Citrus Oncology Enters Into Exclusive Distribution Agreement With Uniphar To Support Access To LYMPHIR Outside U.S.February 10 - Benzinga |
|
See Citius Pharmaceuticals’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for CTXR, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREECitius Pharmaceuticals Earnings & Financial Performance
View all earnings →Citius Pharmaceuticals Insider Trading Activity
View all →| No recent insider transactions on file. |
Citius Pharmaceuticals Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Citius Pharmaceuticals
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
LuminarLAZR |
$42.59 3.7% | $15M | 37 |
 |
WorksportWKSP |
$0.56 3.4% | $9M | 69 |
 |
Foresight AutonomousFRSX |
$1.17 7.8% | $5M | 50 |
 |
Westport Fuel SystemsWPRT |
$1.91 1.1% | $36M | 50 |
 |
AeyeLIDR |
$1.37 0.0% | $64M | 58 |
Explore Citius Pharmaceuticals Data
Frequently Asked Questions: Citius Pharmaceuticals (CTXR)
Citius Pharmaceuticals has an AltIndex AI Score of 47/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
47/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Citius Pharmaceuticals (CTXR) stock is $0.59 with a market cap of $16M.
As of today, Citius Pharmaceuticals’s PE (Price to Earnings) ratio is —.
View the latest Citius Pharmaceuticals insider transactions to see recent buying and selling activity by company executives and directors.
Check the Citius Pharmaceuticals congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The CTXR stock price chart above shows Citius Pharmaceuticals’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Citius Pharmaceuticals technical analysis for RSI, moving averages, and more.
See the stocks similar to Citius Pharmaceuticals section on this page for companies in the same industry ranked by market cap and AI Score.
